Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

Clinical trial NCT02081326 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02081326
Sponsor: Massachusetts General Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type One Diabetes Mellitus, Type I Autoimmune Diabetes Covid19

Start date: 2015-06-01
Primary completion: 2029-07-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.